Medicare Part D drug spending, 2020-2024

What drove gross drug spending up - new drugs, more patients per drug, more fills per patient, or price?

Gross spending (before manufacturer rebates), per CMS "Medicare Part D Spending by Drug", release of 2026-06-25. Method, data and checks.

What drove the $90.0B increase

Per-drug decomposition 2020 → 2024, summed over all drugs (log-mean Divisia)

Growth by therapeutic group

Gross spending by year ($B); hover for values

Concentration

Share of each year's spending held by the top 10 and top 50 drugs

Negotiation-selected drugs

Share of 2024 spending in the drugs CMS selected for price negotiation (10 for 2026, 15 for 2027)

Top drugs

Top 25 drugs by spending change, 2020 → 2024; filter by group or rank year, click a column to sort

Selected drugs detail

Each CMS selected drug and its spending in the dataset

Table view: decomposition and group totals